December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Immunoactivity of Retinal S-Antigen in Retinoblastoma
Author Affiliations & Notes
  • X Ou
    Ophthalmology Zhongshan Opthalmic Center Guangzhou China
  • Footnotes
    Commercial Relationships   X. Ou, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2585. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X Ou; The Immunoactivity of Retinal S-Antigen in Retinoblastoma . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2585.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To study retinal S-antigen expression in human retinoblastoma and assess if there is a correlation between S-antigen immunoactivity and degree of retinoblastoma cell differentiations. Methods:Twenty-three cases of retinoblastoma parafin-embedded tissues were applied for this study. A strain of monoclonal antibody, MabA9C6, which defines an epitope in S-antigen retained in fixed-tissue sections, was used to study S-antigen expression in 23 cases of retinoblastomas. S-antigen was localized by the biotinavidin indirect immunoperoxidase technique and purified MabA9C6 ascites fluid was used with 1:100. The whole proceedure could be finished within a few hours. Results:The S-antigen immunoactivity was observed in different patterns: the "normal" photoreceptor elements incorporated in 5 cases of growing tumors; 5 of 7 Fleurettes and E-W rosettes; and scattered tumor cells in 58% of the cases. Conclusion:Our result suggests that the expression of S-antigen in retinoblastoma may be used to assess the degree of tumor differentiation as another tumor marker in retinoblastoma.

Keywords: 310 aging: visual performance • 306 adenosine • 310 aging: visual performance 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×